Symphony Health

A mid-tier but highly regarded competitor in the pharmaceutical data and analytics space, known for transparent longitudinal patient-level data assets and strong managed markets analytics capabilities.

Symphony Health is a healthcare data and analytics company that provides comprehensive prescription and medical claims data, patient-level analytics, and market intelligence to pharmaceutical manufacturers, biotech firms, and life sciences organizations. Its core offerings include longitudinal patient data, prescriber-level analytics, and market performance tracking tools that help clients understand treatment patterns, patient journeys, and commercial opportunities across therapeutic areas. The company aggregates data from a vast network of pharmacies, payers, and healthcare providers to deliver actionable insights at scale. Founded in the early 2000s and headquartered in Horsham, Pennsylvania, Symphony Health built a strong reputation for the breadth and depth of its claims data assets, particularly its PatientSource and DX/RX datasets. These products became widely used by pharmaceutical brand teams, managed markets groups, and market access professionals seeking to optimize launch strategies, monitor competitive dynamics, and measure promotional effectiveness. The company competed directly with IQVIA (formerly IMS Health) and other healthcare data giants, differentiating itself through data transparency and flexible analytics delivery. Symphony Health was acquired by PRA Health Sciences in 2017, which was itself subsequently acquired by ICON plc in 2021, making Symphony Health part of one of the world's largest clinical research organizations. While the Symphony Health brand has continued to operate within this larger corporate structure, its data and analytics capabilities have been integrated into ICON's broader life sciences services portfolio, serving pharmaceutical and biotech clients navigating increasingly complex commercial and clinical landscapes.

• 2001Founded